Back to Search Start Over

A Phase I Trial Assessing the Feasibility of Romidepsin Combined with Brentuximab Vedotin for Patients Requiring Systemic Therapy for Cutaneous T-Cell Lymphoma

Authors :
Stefan K. Barta
Tatyana A. Feldman
Jennifer A. DeSimone
Ellen Kim
Karthik Devajaran
Yibin Yang
Henry C. Fung
Tafseer Mahvish
Shazia Nakhoda
Nadia Khan
Source :
Blood. 140:6543-6544
Publication Year :
2022
Publisher :
American Society of Hematology, 2022.

Subjects

Subjects :
Immunology
Cell Biology
Hematology
Biochemistry

Details

ISSN :
15280020 and 00064971
Volume :
140
Database :
OpenAIRE
Journal :
Blood
Accession number :
edsair.doi...........3ea4ea3df74651baa294f24a48a0cbe9

Tools

Authors Abstract Subjects Details